Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05849610
Title Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma (GEM-TECTAL)
Acronym GEM-TECTAL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trials i Pujol NOT_YET_RECRUITING Badalona Spain Details
Hospital Clinic i Provincial de Barcelona NOT_YET_RECRUITING Barcelona Spain Details
Hospital Doce de Octubre RECRUITING Madrid 28041 Spain Details
Hospital Virgen de la Arrixaca RECRUITING Murcia Spain Details
Clinica Universidad de Navarra RECRUITING Pamplona Spain Details
Hospital Universitario de Salamanca RECRUITING Salamanca Spain Details
H. Universitario Marqués de Valdecilla RECRUITING Santander Spain Details
Complejo Hospitalario Santiago (CHUS) RECRUITING Santiago De Compostela Spain Details
Hospital Vírgen del Rocío RECRUITING Sevilla Spain Details
Hospital Universitari i Politecnic la Fe NOT_YET_RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field